Page last updated: 2024-10-26

dipyridamole and Dysgeusia

dipyridamole has been researched along with Dysgeusia in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Dysgeusia: A condition characterized by alterations of the sense of taste which may range from mild to severe, including gross distortions of taste quality.

Research Excerpts

ExcerptRelevanceReference
"A case of dysgeusia during treatment with dipyridamole for congestive heart failure is reported."5.27Dysgeusia after high dose dipyridamole treatment (short communication). ( Finci, L; Goy, JJ; Sigwart, U, 1985)
"A case of dysgeusia during treatment with dipyridamole for congestive heart failure is reported."1.27Dysgeusia after high dose dipyridamole treatment (short communication). ( Finci, L; Goy, JJ; Sigwart, U, 1985)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goy, JJ1
Finci, L1
Sigwart, U1

Other Studies

1 other study available for dipyridamole and Dysgeusia

ArticleYear
Dysgeusia after high dose dipyridamole treatment (short communication).
    Arzneimittel-Forschung, 1985, Volume: 35, Issue:5

    Topics: Aged; Arrhythmias, Cardiac; Dipyridamole; Dysgeusia; Humans; Male; Taste Disorders

1985